Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK106892, U01 DK106893, U01 DK106853, U01DK106786, U01 DK106858, U01 DK106827, U01 DK106898, U01 DK106908)
Received: 10 September 2020
Accepted: 24 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: Ethics approval is approved by single IRB ADVARRA #Pro00032238 with individual research center approval via reliance agreements. Waiver of written consent with implied consent upon return of surveys is approved for women enrolled in general population and written informed consent is obtained from each participant enrolled in the in person clinical center evaluation portion of the study.
: Not applicable.
: The authors declare that they have no competing interests.